To listen to an audio podcast, mouse over the title and click Play. Open iTunes to download and subscribe to podcasts.
CPT: Pharmacometrics & Systems Pharmacology is pleased to offer our own podcast, PSPod. Join us as we delve into advances in quantitative methods as applied in pharmacology, physiology and therapeutics in humans.
||CleanQuantitative Systems Toxicology Modeling with guest Dr. Paul Watkins||On today’s episode, Dr. Paul Watkins, the Howard Q. Ferguson Distinguished Professor at Eshelman School of Pharmacy, University of North Carolina at Chapel Hill and the Director of the University of North Carolina Institute for Drug Safety Sciences, d||8/30/2018||Free||View in iTunes|
||CleanReverse Translation Special Joint Episode||On this special joint episode of ClinPharmPod, the official podcast for Clinical Pharmacology and Therapeutics, and PSPod, the official podcast of CPT: Pharmacometrics and Systems Pharmacology Karthik Venkatakrishnan from Takeda Pharmaceuticals and Ass||3/7/2018||Free||View in iTunes|
||Clean“Thoughtflow” with guests Mike Smith, Justin Wilkins, and Amy Cheung||On today’s episode, Mike Smith from Pfizer, Justin Wilkins from Occams, and Amy Cheung from AstraZeneca discuss “Thoughtflow”, a set of standards compiled by the DDMoRe consortium to help facilitate the capture, storage, and reporting of knowledge||11/10/2017||Free||View in iTunes|
||CleanPharmacometrics for Immuno-oncology with guest Iñaki F. Trocóniz||This episode features Dr. Iñaki F. Trocóniz discussing how pharmacometric techniques can be used to counteract immuno-response suppression by tumor cells. Read his commentary from the January 2017 issue here. Also, please find additional CPT:PSP arti||7/19/2017||Free||View in iTunes|
||CleanModels of Blood Coagulation with guest Satyaprakash Nayak||This episode features Dr. Satyaprakash Nayak discussing application of advanced pharmacometrics and quantitative systems pharmacology in hematology. Read his article from the July 2016 issue here. Also, please find additional CPT:PSP articles related to||11/4/2016||Free||View in iTunes|
||CleanGood Practices in Model-Informed Drug Discovery and Development with guests Scott Marshall, Sandra Visser, and Amy Cheung||In this episode, Drs. Scott Marshall from Pfizer, Sandra Visser from Merck, and Amy Cheung from AstraZeneca discuss “Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation”: their White Paper||5/9/2016||Free||View in iTunes|
||CleanCommunicating Systems Pharmacology and Pharmacometrics Models with guest Peter Bonate||In this episode, Peter Bonate from Astellas, discusses effective communication in systems pharmacology and pharmacometric models. You can read a review of Dr. Bonate’s book Be a Model Communicator and Sell Your Models to Anyone, reviewed by Ellen L||2/26/2016||Free||View in iTunes|
||CleanExisting Practice to Modeling Approaches with guests Sandra Visser and Anne Chain||This episode features Sandra Visser and Anne Chain from Merck & Co/MSD, discussing existing practice and modeling approaches and some thoughts with regard to future directions for modeling to assess and predict cardiovascular liabilities of new drugs||1/15/2016||Free||View in iTunes|
||CleanDrug Disease Resources Consortium with guest Lutz Harnisch||This episode features Lutz Harnisch from Clinical Pharmacology Pharmacometrics at Pfizer, discussing the Drug Disease Model Resources (DDMoRe) consortium. His Perspective article that introduces the activities of the DDMoRe consortium can also be found||9/18/2015||Free||View in iTunes|
||CleanDatabases as Tools in Pharmacometrics and Systems Pharmacology with guest Shiew-Mei Huang||In this episode, we interview Dr. Shiew-Mei Huang, Deputy Director, Office of Clinical Pharmacology, Center for Drug Evaluation and Research at the Food and Drug Administration about a drug interaction database–a tool for evaluating the impact of r||6/1/2015||Free||View in iTunes|
||CleanInfectious Diseases and the Role of Pharmacometrics with guest Steven E. Kern||In this episode, we interview Dr. Steven E. Kern, Deputy Director of Quantitative Sciences at the Bill and Melinda Gates Foundation, about infectious diseases in context of the possibilities for pharmacometrics and systems pharmacology to contribute to||3/2/2015||Free||View in iTunes|